Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells
β Scribed by Yoshihiro Kikuchi; Tsunekazu Kita; Junko Hirata; Masanori Fukushima
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 609 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0167-7659
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The ability of lonidamine, an energolytic derivative of indazolecarboxylic acid, to modulate the cytotoxicity of cisplatin was investigated in human ovarian-cancer cell lines sensitive (A2780) or with experimentally induced resistance (A2780/cp8) to the alkylating agent. A 24-hr post-incubation with
## Abstract Lipocalinβtype prostaglandin D synthase (LPGDS; PGH~2~Dβisomerase; EC 5.3.99.2) is a bifunctional protein first identified in the mammalian brain. It acts as a PGD~2~βproducing enzyme and a retinoid transporter. Recent studies have shown that LPGDS is anomalously expressed in ovarian tu
The human tumor stem cell assay (HTSCA) has been used to study the in vitro sensitivity rates of anticancer drugs used in the treatment of 115 patients with previously untreated and relapsing ovarian cancer. The data from these studies have identified patterns of cross resistance and residual sensit